SNDL Inc. (NasdaqCM: SNDL)
Health Care · Pharmaceuticals · CA
$1.37
0.00% today · -42.9% 1Y
SNDL Inc. (NasdaqCM: SNDL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $340.67M and employs 2,751 people.
Over the last twelve months the share price has lost 42.9%, trading between 1.17 and 2.89.
Tweenvest scores SNDL Inc. across four factors: quality 62/100, value 68/100, growth 8/100. Its strongest factor is value.
SNDL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $340.67M
- Revenue (TTM)
- $653.75M
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- $2.89
- 52-week low
- $1.17
- Avg volume (3M)
- —
- Shares outstanding
- 248.66M
- Employees
- 2,751
- Next earnings
- —
About SNDL Inc.
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
- ISIN
- CA83307B1013
- Founded
- 2006
- Listed since
- Aug 1, 2019
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.